Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ raptor resources limited

The beauty is while the analysis team prepare the top-line...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 318 Last

Share
Profile

Follow
mineup

452 Posts.

20

01/06/17

09:52

Post #: 25032894
Share

Originally posted by MyBentley ↑

This is what I see,...

I am waiting on top line FDA results.

I expect Resapp results to be equal if not better than Australian pediatric data results which are now excellent over a very long period.

RAP team at Uniquest under Dr Abeyratme have been fine tuning Resapp algorithms in Australian pediatric trials and this still continues.

RAP team trained US collection staff as to the optimum quiet room for collection of cough sounds.

RAP team trained US collection staff as to optimum distance to hold phone for recording of sounds.

All testing collection data collected based on optimum results gained in Australian pediatric trials.

Commercial deals may start at three of the biggest and most prestigious hospitals in USA on release of top line results.

There are so many ways RAP could commercialize Resapp before FDA approval based on top line results from SMARTCOUGH-C.

RAP may offer Texas, Cleaveland and MGH unlimited use for 2 years for a fee?

Many ways to commercialize Resapp before FDA approval.

Luv RAP
MB

Expand

The beauty is while the analysis team prepare the top-line results, in parallel 'ResApp and its FDA consultants will finalise the de novo submission for ResAppDx'.

So this top line news are now in the spot light presentation markets such as Singapore and Hongkong today and surely in Shanghai too.

I would expect buyers to start their collection and accumulations from now. May hit 60c by early July.

Go on RAP

RAP Price at posting: 31.0¢ Sentiment: Buy Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

HLX

Helix investor makes partial takeover bid, proposing board changes

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

There are more pages in this discussion • 436 more messages in this thread...

First 318 Last

Add RAP (ASX) to my watchlist

The beauty is while the analysis team prepare the top-line...

Top Stories

Lendlease sells off US east coast construction operations in latest global divestment push

Helix investor makes partial takeover bid, proposing board changes

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Featured News